Prolonged infusion of gemcitabine in patients with platinum resistant or refractory recurrent ovarian carcinoma: A phase II study Of GEICO (Spanish Group for investigation on ovarian cancer)

5101 Background: Preclinical and clinical evidence suggests that a prolonged infusion may be more effective than the standard 30-minute infusion of gemcitabine. To investigate the activity and toxi...